Curis

Forma Therapeutics Holdings, Inc is a biopharmaceutical company based in Watertown, MA, specializing in the development of innovative therapies for various disease areas. With a focus on science and technology, they strive to create sustainable business practices while partnering with other organizations. Their commitment to progress is evident through their collective efforts and accountability, as showcased in their R&D pipeline and financial results. Novo Nordisk, a global healthcare company, is actively involved in the acquisition of fill-finish sites and has recently filed their annual report with the SEC. With a significant increase in sales, they continue to make strides in the industry, offering approved medicines for various indications. Novo Nordisk's dedication to patient help, supplier assistance, and ESG reporting is evident through their online presence and global reach.Generated from the website

Vincent OB/GYN Service in Boston provides patients at Mass General with access to a diverse network of highly skilled physicians, the majority of whom are esteemed Harvard Medical School faculty members. Many of the physicians at Vincent OB/GYN Service are recognized leaders in their respective fields, ensuring that patients receive top-quality care and expertise for their obstetric and gynecological needs. Generated from their website's infomation

Curis is a therapeutic drug development company. Its technology focus is on regulatory pathways that control repair and regeneration. Curis product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer (in partnership with Genetech), kidney disease (in partnership with Ortho Biotech), neurological disorders (in partnership with Wyeth), hair growth (in partnership with Proctor & Gamble) and cardiovascular disease (in partnership with Internal Development).